The CMS said the program, which went into effect last year to stabilize Part D premiums and enrollment, isn’t needed anymore.

The guidelines have changed recently as new testing options have become available. Getting screened doesn’t have to be ...

While there has been a recent increase among Medicare recipients in genomic testing that helps match cancer patients to the ...

Medicare coverage of next-generation sequencing may have spurred an increase in the number of patients receiving genomic ...

Will Tran, a rising senior rower and computer science major, created RowIQ, which provides an in-depth look on how rowers can ...

Tirzepatide works the same way. It is the active ingredient in both Mounjaro and Zepbound, both made by Eli Lilly. Mounjaro ...

The Academy strongly recommends that patients should not stop their ongoing systemic immunosuppressive therapy without consulting their physicians. To better serve patients and their physicians, the ...